DUSE/B43 (DUSE/B43)

Dusseldorf Stock Exchange: DUSE/B43 · EUR

€30.8

+1.45 (+4.9%)· Recorded snapshot

Market cap	1.7B
Net income (ttm)	-140.3M
EPS (ttm)	-€4.07
Volume	10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -140.3M
EPS (ttm): -€4.07
Market cap: 1.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.5P50 19.1P75 28.3

Trailing P/En/a

P25 14.1P50 23.7P75 38.5

ROEn/a

P25 -50.4P50 0.5P75 12

ROICn/a

P25 -29.8P50 1.9P75 10.7

Benchmarks · 1M

S&P 500+0.5%

Nasdaq Composite-2.4%

Dow Jones Industrial Average+1.8%

Russell 2000+1.8%

All DUSE/B43 indicators

Market & fundamental data

Available fields

118

Groups with data

Currency

USD

Showing 118 of 118 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-11-12
Employees	104
Enterprise value	EUR 1.6B
Exchange	Dusseldorf Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	2019
Industry	Biotechnology
Is primary listing	No
ISIN number	US3371851029
Last refreshed	2026-10-28
Market cap	EUR 1.7B
Next earnings date	2026-11-12
Price	EUR 30.75
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-12
Symbol	duse/B43
Website	https://www.firsttracksbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-13.24%
FCF / EV yield	-6.93%
FCF yield	-6.33%
P/B ratio	11.58x
Price / tangible book value	11.58x
Sector forward P/E	14.82x
Sector P/E	39.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROCE	-99.35%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -48,142
Depreciation and amortization	EUR 450,443
EBIT	EUR -148.4M
EBITDA	EUR -148M
EPS	EUR -4.07
Financing cash flow	EUR 31.3M
Free cash flow	EUR -108.4M
Free cash flow minus SBC	EUR -140.5M
Investing cash flow	EUR 185.3M
Net cash flow	EUR 108.3M
Net income	EUR -140.3M
Operating cash flow minus SBC	EUR -140.5M
Operating income	EUR -148.4M
Stock-based compensation	EUR 32.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 4.17
Debt / equity	0.03
Long-term assets	EUR 494,045
Long-term liabilities	EUR 1.4M
Net cash (debt)	EUR 143.3M
Net cash / market cap	8.37%
Net debt / equity	-0.97
Piotroski F-Score	1
Property, plant and equipment	EUR 4.9M
Shareholders' equity	EUR 147.7M
Tangible book value	EUR 147.7M
Tangible book value per share	EUR 4.17
Total assets	EUR 160.3M
Total cash	EUR 147.1M
Total debt	EUR 3.8M
Total liabilities	EUR 12.6M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	EUR 159.8M
Current liabilities	EUR 11.2M
Current ratio	14.28
Net working capital	EUR -248,585
Quick ratio	13.91
Working capital	EUR 144.7M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	4.95%
1M price change	-0.39%
1M total return	-0.39%
1W price change	4.95%
1W total return	4.95%
20-day SMA	EUR 34.99
3M price change	14.02%
3M total return	14.02%
50-day SMA	EUR 35.18
52-week high	EUR 42.66
52-week high date	2026-08-11
52-week low	EUR 13.14
52-week low date	2026-06-03
All-time high	EUR 42.66
All-time high date	2026-08-11
All-time low	EUR 13.14
All-time low date	2026-06-03
Average true range (ATR)	EUR 2.41
Average volume	5.9
Change from 52-week high	-27.91%
Change from 52-week low	134.02%
Change from all-time high	-27.91%
Change from all-time low	134.02%
Change from open	-4.65%
Day's gap	10.07%
Dollar volume	EUR 308
High price	EUR 35.00
Low price	EUR 30.75
Monthly RSI	0
Open price	EUR 32.25
Position in 52-week range	0%
Previous close	EUR 29.30
Price vs 20-day SMA	-12.13%
Price vs 50-day SMA	-12.58%
Relative volume	1.71
RSI	42.43
Sharpe ratio	1.55
Sortino ratio	3.27
Volume	10
Weekly RSI	60.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26.2M
Shares change (QoQ)	0.32%
Shares held by insiders	1.56%
Shares held by institutions	66.05%
Short ratio	8.3 days

Deeper analysis on DUSE/B43

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DUSE/B43 report

Is a complete DUSE/B43 research report available?

No complete published report is available for duse/B43 (DUSE/B43) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DUSE/B43 (DUSE/B43)

Price

Financial snapshot

Fair-value bridge

Latest news · DUSE/B43

Valuation

Balance sheet

Trading

Next earnings

Sector percentile context

All DUSE/B43 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on DUSE/B43

Frequently asked questions